KRT19 and bladder transitional cell carcinoma: Therefore, we prepared a TMA containing 50 BLCA samples, namely, the Xiangya BLCA TMA, and performed multicolor staining on TBX3+ tumor cells (TBX3+ CK19+), CD8+ T cells, and CAFs (α-SMA+).